Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Jakub Porzycki | Nurphoto | Getty ImagesNovo Nordisk on Wednesday reported a third-quarter beat on sales of its blockbuster weight-loss drug Wegovy and narrowed its 2024 full-year growth guidance.Company shares…